Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 28674028

Gemtuzumab ozogamicin in infants with AML: results from the Children's Oncology Group trials AAML03P1 and AAML0531.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2017 Aug 17
First author
Guest EM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Guest EM
      type
      Author
    2. name
      Aplenc R
      type
      Author
    3. name
      Sung L
      type
      Author
    4. name
      Raimondi SC
      type
      Author
    5. name
      Hirsch BA
      type
      Author
    6. name
      Alonzo TA
      type
      Author
    7. name
      Gerbing RB
      type
      Author
    8. name
      Wang YJ
      type
      Author
    9. name
      Kahwash SB
      type
      Author
    10. name
      Heerema-McKenney A
      type
      Author
    11. name
      Meshinchi S
      type
      Author
    12. name
      Gamis AS
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Guest EM
      type
      Author
    2. name
      Aplenc R
      type
      Author
    3. name
      Sung L
      type
      Author
    4. name
      Raimondi SC
      type
      Author
    5. name
      Hirsch BA
      type
      Author
    6. name
      Alonzo TA
      type
      Author
    7. name
      Gerbing RB
      type
      Author
    8. name
      Wang YJ
      type
      Author
    9. name
      Kahwash SB
      type
      Author
    10. name
      Heerema-McKenney A
      type
      Author
    11. name
      Meshinchi S
      type
      Author
    12. name
      Gamis AS
      type
      Author
    bibliography ids
    1. nci-bib-603da550c42e009adecf3db5
    book metadata
    content sha256
    2f607ca3570a0d1297a6c2a9d37b4f9e39b88b4ebb0e6871d54f8c1da9a618f5
    document type
    citation
    dois
    1. 10.1182/blood-2017-01-762336
    electronic publication date
    display
    2017 Jul 3
    precision
    day
    year
    2017
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:28674028
    immutable id
    pubmed:28674028@2f607ca3570a0d1297a6c2a9d37b4f9e39b88b4ebb0e6871d54f8c1da9a618f5
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    7
    name
    Blood
    nlm unique id
    7603509
    pages
    943-945
    volume
    130
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      28674028
      provenance
      batch id
      1c173f0e18be0c6d461b
      provider
      NCBI PubMed ESummary
      record sha256
      fa08fb8708f49a292a291f8f1998654890f0e2e5e22b780385a4605de2155953
      response sha256
      27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
      retrieved at
      2026-09-09T23:47:25.975513+00:00
      publication date
      display
      2017 Aug 17
      precision
      day
      year
      2017
      publication types
      1. Letter
      2. Meta-Analysis
      3. Research Support, N.I.H., Extramural
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/28674028/
      title
      Gemtuzumab ozogamicin in infants with AML: results from the Children's Oncology Group trials AAML03P1 and AAML0531.

      Preserved source evidence · Not medical advice